Home
Our ServicesConnect Education WorkshopsTagged: Treatment
HomeOur ServicesConnect Education WorkshopsTagged: Treatment
Connect Education Workshops About Treatment
You can also browse all resources about treatment»
Upcoming Workshops
For All Cancers
For Colorectal Cancer
For Gastrointestinal Stromal Tumors
For Lymphoma
For Melanoma
Past workshops
For All Cancers
- Managing Eye and Vision Changes Related to Cancer Treatments
- Trends in Oncology & Treatment Planning: A Guide to Getting the Best CarePart I of Life with Cancer: A Guide to Getting the Best Care
- Understanding the Different Names for Biomarker Testing and Their Role in Selecting the Best Treatment for YouPart II of What You Need to Know About Biomarkers in the Treatment of Cancer Makes All the Difference in the World
- Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of CancerPart I of What You Need to Know About Biomarkers in the Treatment of Cancer Makes All the Difference in the World
- Clinical Trials: How They Transform the Treatment of Cancer
- Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects
- Current Perspectives on the Future of Cancer Research
- How Health Care Disparities May Influence Your Cancer Treatment
- Diverse Populations Participating in Decisions about Your Care
- Managing Eye and Vision Changes Related to Cancer Treatments
- Understanding the Different Names for Biomarker Testing & Their Role in Selecting the Best Treatment for YouPart II of The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
- Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects
- Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of CancerPart I of The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
- Diverse Populations Participating in Decisions About Your Care With Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
- Understanding Diagnostic Technologies and Biomarkers
- Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
- What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
- Cancer and The Workplace: Understanding Your Legal ProtectionsPart III of Life with Cancer: A Guide to Getting the Best Care
- Understanding the Costs of Care and Your Health Care CoveragePart II of Life with Cancer: A Guide to Getting the Best Care
For Acute Lymphoblastic Leukemia
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
For Acute Myeloid Leukemia
For Basal Cell Cancer
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
For Bladder Cancer
For Bone Cancer
For Brain Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Glioblastoma in Adults: Treatment Updates
For Breast Cancer
- Breast Cancer in Younger Women: New Treatment Options
- Breast Cancer in Men: Diagnosis, Treatment and Survivorship
- Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer
- Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
- Triple Negative Breast Cancer and African American Women
- Updates from the American Society of Clinical Oncology (ASCO) 2024 on Triple Negative Breast Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life
- Breast Cancer in Younger Women: New Treatment Options
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Cervical Cancer
For Chronic Lymphocytic Leukemia
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia
- Updates on CAR T-cell Therapies
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Managing Chronic Lymphocytic Leukemia (CLL) and Its ComplicationsPart IV of Life with Chronic Lymphocytic Leukemia (CLL)
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Life with Chronic Lymphocytic Leukemia (CLL)
- CAR T-Cell Therapy: What’s New
For Chronic Myelogenous Leukemia
For Colorectal Cancer
- Advances in the Treatment of Colorectal Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Advances in the Treatment of Colorectal Cancer
For Cutaneous T-Cell Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Diffuse Large B-Cell Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Endometrial Cancer
For Follicular Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Update on Follicular Lymphoma
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Gastric Cancer
For Gastrointestinal Stromal Tumors
For Glioblastoma
For Head and Neck Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Oral, Head and Neck Cancer: Treatment Updates
- Treatment Update in Oral and Head and Neck Cancer
For Hodgkin Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Kidney Cancer
For Leukemia
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia
- Updates on CAR T-cell Therapies
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Managing Chronic Lymphocytic Leukemia (CLL) and Its ComplicationsPart IV of Life with Chronic Lymphocytic Leukemia (CLL)
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Life with Chronic Lymphocytic Leukemia (CLL)
- CAR T-Cell Therapy: What’s New
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
For Liver Cancer
For Lung Cancer
- Non-Small Cell Lung Cancer: Biomarker Testing and Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: Biomarker Testing and TreatmentPart II of Living with Non-Small Cell Lung Cancer
- Diverse Populations Living with Non-Small Cell Lung Cancer
- Update on Small Cell Lung CancerPart I of Living with Small Cell Lung Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on Primary Central Nervous System Lymphoma (PCNSL)
- Update on CAR T-Cell Therapies
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Update on Follicular Lymphoma
- CAR T-Cell Therapy: What’s New
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Mantle Cell Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Marginal Zone Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Melanoma
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Mesothelioma
For Metastatic Breast Cancer
- Breast Cancer in Younger Women: New Treatment Options
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life
- Breast Cancer in Younger Women: New Treatment Options
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Multiple Myeloma
- Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Diverse Populations Living with Multiple Myeloma: Treatment Advances
- Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
For Myelodysplastic Syndromes
For Myelofibrosis
For Myeloproliferative Neoplasms
- Updates on CAR T-cell Therapies
- Progress in the Treatment of Myeloproliferative Neoplasms (MPNs)Part I of Living with Myeloproliferative Neoplasms
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Managing Treatment Side Effects, Aches and Pains from Myeloproliferative Neoplasms (MPNs)Part II of Living with Myeloproliferative Neoplasms (MPNs)
- Progress in the Treatment of Myeloproliferative Neoplasms (MPNs)Part I of Living with Myeloproliferative Neoplasms (MPNs)
For Non-Hodgkin Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Ovarian Cancer
- Update on the Treatment of Ovarian Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Medical Update on Ovarian Cancer
For Pancreatic Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Pancreatic Cancer: Treatment Update
For Peripheral T-Cell Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Polycythemia Vera
For Prostate Cancer
- Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
For Renal Cell Cancer
For Sarcoma
For Skin Cancer
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
For Small Lymphocytic Lymphoma
- Updates on CAR T-cell Therapies
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
For Squamous Cell Cancer
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
For Stomach Cancer
For Thyroid Cancer
For Triple Negative Breast Cancer
- Breast Cancer in Younger Women: New Treatment Options
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
- Triple Negative Breast Cancer and African American Women
- Updates from the American Society of Clinical Oncology (ASCO) 2024 on Triple Negative Breast Cancer
- Breast Cancer in Younger Women: New Treatment Options
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy